Immunovant Inc. Common Stock vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.55 (market cap $339.46M). The key difference: Immunovant Inc. Common Stock is far larger — about 19.5× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| IMVT | XDTE | |
|---|---|---|
Market Cap | $6.62B | $339.46M |
Volume | 1,131,364 | 214,614 |
Sector | Health | Income / Options Overlay |
52-Week High | $44.96 | $44.76 |
52-Week Low | $17.03 | $36.00 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $5.72B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →